FdaApplication
ANDA 213731
Identifiers
- fda_app_no: ANDA213731
Properties
| Property | Value |
|---|---|
| applicant_name | APOTEX INC |
| application_type | ANDA |
| approval_date | 2025-02-24 |
Products (5)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| BREXPIPRAZOLE | BREXPIPRAZOLE | 1MG | TABLET;ORAL |
| BREXPIPRAZOLE | BREXPIPRAZOLE | 2MG | TABLET;ORAL |
| BREXPIPRAZOLE | BREXPIPRAZOLE | 0.5MG | TABLET;ORAL |
| BREXPIPRAZOLE | BREXPIPRAZOLE | 3MG | TABLET;ORAL |
| BREXPIPRAZOLE | BREXPIPRAZOLE | 0.25MG | TABLET;ORAL |
5 products